News
A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...
Discover 7 crucial cancer warning signs often missed during routine medical exams and learn how to recognize these subtle ...
6h
News-Medical.Net on MSNNew RNA-based blood test offers insight into cancer and tissue damageStanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...
4d
News-Medical.Net on MSNSome lung cancer patients maintain long-term control after stopping immunotherapyA subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...
Patients in Medicaid expansion states had more timely treatment, a study from the Houston-based University of Texas MD Anderson Cancer Center found. The study, published April 11 in The Annals of ...
Some patients with non-small cell lung cancer (NSCLC) who had to stop taking immune checkpoint inhibitors (ICIs) because of side effects caused by their immune system still managed to keep their ...
12d
Live Science on MSN'Fingerprints of cancer' found with infrared lightFlashes of infrared light can detect signs of cancer in a patient's blood, new research suggests. In a new study, scientists ...
A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, ...
When Paul Hall was diagnosed with stage 4 lung cancer in October 2021, he said, “I’m not quitting.” ...
Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...
During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results